P6325JPH2 p.(Thr161Lys) is a Finnish founder mutation associating to hypertrophic cardiomyopathy with or without systolic heart failure and conduction abnormalities
Juha Koskenvuo(University of Helsinki), Tiina Heliö(Helsinki University Hospital), Katriina Aalto‐Setälä(Tampere University), Piia Suursalmi(Tampere University Hospital), Krista Leivo(University of Helsinki), Sari Vanninen(Tampere University Hospital), Tero‐Pekka Alastalo(Quest Diagnostics (United States)), Ismo Anttila(Seinäjoki University of Applied Sciences), Eija H. Seppälä(Blueprint Genetics (Finland)), Samuel Myllykangas, Antti-Pekka Annala(Seinäjoki University of Applied Sciences), Olli Pitkänen(Helsinki University Hospital)
Cited by 1
Related Papers
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
|Cell|1992|2.3k